Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization

Mehul R. DalalEmployee of Sanofi US at the time of the study; ;Millennium Pharmaceuticals Inc., Cambridge, MA, USA; Correspondence[email protected]

Mahmood R. KazemiEmployee of Sanofi US at the time of the study; ;Abbott Diabetes Care, Alameda, CA, USA;

Fen YeTechdata Service LLC, King of Prussia, PA, USA

Figures & data

Table 1. Baseline demographics and clinical characteristics (all patients).

Download CSV Display Table

Figure 1. Basal insulin discontinuation by month for those who discontinued basal insulin treatment within 1 year of initiation.

Table 2. Adjusted hazard ratio for risk of treatment discontinuation within 12 months of follow-up (Cox regression analysis of all patients).

Download CSV Display Table

Table 3. Healthcare resource utilization at 1 year follow-up (patients with at least 1 year follow up).

Download CSV Display Table

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization

Table 1. Baseline demographics and clinical characteristics (all patients).

Table 2. Adjusted hazard ratio for risk of treatment discontinuation within 12 months of follow-up (Cox regression analysis of all patients).

Table 3. Healthcare resource utilization at 1 year follow-up (patients with at least 1 year follow up).

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization

Figures & data

Table 1. Baseline demographics and clinical characteristics (all patients).

Table 2. Adjusted hazard ratio for risk of treatment discontinuation within 12 months of follow-up (Cox regression analysis of all patients).

Table 3. Healthcare resource utilization at 1 year follow-up (patients with at least 1 year follow up).

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date